AN EXAMINATION OF LOW AVERAGE DOSE AS A QUALITY MEASURE OF THE NEED FOR ANTICOAGULATION MANAGEMENT AMONG THE ELDERLY
Author(s)
Benjamin F Banahan III, PhD, Principal Scientist, Noel E Wilkin, PhD, RPh, Interim Associate Provost, Clive M Mendonca, RPh, Graduate Assistant University of Mississippi, University, MS, USA
Presentation Documents
Objective: The objective was to evaluate the relationship between low dose warfarin therapy and hospital utilization. This information will help to evaluate this as a quality of care indicator in elderly patients. Methods: An issue in chronic warfarin therapy is the availability of time and resources necessary to adequately manage patients on anticoagulation therapy. Providers may err on the side of under-dosing due to fears of bleeding episodes. Medicare Part D and A records for 2006 were pulled for all non-ESRD, chronic warfarin users in California, Florida, and Mississippi age 65+. Chronic warfarin users were defined as patients with 3+ warfarin prescriptions covering 180+ days of therapy. Average dose was computed by dividing the total mgs of warfarin dispensed from the first prescription to the next to last prescription and dividing by the number of days between the first and last prescription fills. Low average dose was defined as
Conference/Value in Health Info
2008-05, ISPOR 2008, Toronto, Ontario, Canada
Value in Health, Vol. 11, No. 3 (May/June 2008)
Code
PIH28
Topic
Economic Evaluation, Health Service Delivery & Process of Care, Specialized Treatment Areas
Topic Subcategory
Cost/Cost of Illness/Resource Use Studies, Hospital and Clinical Practices, Personalized & Precision Medicine, Quality of Care Measurement, Treatment Patterns and Guidelines
Disease
Geriatrics